SHERI AMMONS: Open Payments
NPI 1306287263 · BATON ROUGE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,234 in 95 payments from 21 companies in 2025. Trend: 2023 $428 · 2024 $1,211 · 2025 $3,234
Food & beverage: $3,151Education: $43Long term medical supply or device loan: $40
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 13 | $768 |
| Novo Nordisk Inc | 13 | $532 |
| Dexcom, Inc. | 15 | $389 |
| Sequel Med Tech, LLC | 5 | $226 |
| Medtronic, Inc. | 10 | $213 |
| Insulet Corporation | 7 | $159 |
| Corcept Therapeutics | 2 | $146 |
| Lilly USA, LLC | 6 | $134 |
| Genentech, Inc. | 1 | $120 |
| BETA BIONICS, INC. | 1 | $113 |
Products named: FREESTYLE LIBRE 3, Dexcom G6 Transmitter, Wegovy, Ozempic, TWIIST, MINIMED 780G, Omnipod, Korlym.
Industry payments across LA — which companies pay providers there.
